AADI BIOSCIENCE
Aadi Bioscience, Inc. is a biopharmaceutical company developing precision therapies for genetically-defined cancers. Aadi’s primary goal is to bring transformational therapies to cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes, where other mTOR inhibitors have not or cannot be effectively exploited due to problems of pharmacology, effective drug delivery, safety, or effective targeting to the disease site. Aadi’s initial focus is the treatment of an ultra-rare cancer PEComa, also known as perivascular epithelioid cell tumor.
AADI BIOSCIENCE
Industry:
Biopharma Biotechnology Life Science
Founded:
2011-09-30
Address:
Pacific Palisades, California, United States
Country:
United States
Website Url:
http://www.aadibio.com
Total Employee:
51+
Status:
Active
Contact:
(424) 744-8055
Total Funding:
178 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon WordPress Google Universal Analytics
Similar Organizations
hC Bioscience
hC Bioscience is an innovator and pioneer of protein editing using context agnostic engineered tRNA.
Principia Biopharma
Principia Biopharma is dedicated to bringing oral therapies to patients with significant unmet medical needs in immunology & oncology.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Current Advisors List
Board_member
Advisor
Board_member
Board_member
Board_member
Current Employees Featured
Marcy Graham Senior Vice President, Investor Relations & Corporate Communications @ Aadi Bioscience
Senior Vice President, Investor Relations & Corporate Communications
2022-05-01
Brendan Delaney Chief Operating Officer @ Aadi Bioscience
Chief Operating Officer
2021-09-01
Neil Desai Founder, CEO and President @ Aadi Bioscience
Founder, CEO and President
Nancy Jorgesen Vice President, Project Leadership @ Aadi Bioscience
Vice President, Project Leadership
2018-11-01
Berta Grigorian VP, Clinical Operations @ Aadi Bioscience
VP, Clinical Operations
Loretta Itri CMO @ Aadi Bioscience
CMO
2021-10-01
Founder
Investors List
Star Summit Ventures
Star Summit Ventures investment in Series A - Aadi Bioscience
Hermed Capital
Hermed Capital investment in Series A - Aadi Bioscience
Vivo Capital
Vivo Capital investment in Series A - Aadi Bioscience
Celgene
Celgene investment in Series A - Aadi Bioscience
Decheng Capital
Decheng Capital investment in Series A - Aadi Bioscience
3B Future Health Fund
3B Future Health Fund investment in Series A - Aadi Bioscience
Key Employee Changes
Official Site Inspections
http://www.aadibio.com Semrush global rank: 2.52 M Semrush visits lastest month: 6.99 K
- Host name: ec2-35-172-144-95.compute-1.amazonaws.com
- IP address: 35.172.144.95
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Aadi Bioscience"
Corporate Overview - AADI Bio
Corporate Overview. JUNE 2021. www.aadibio.com . Aadi Bioscience Inc., Pacific Palisades, CA 90272, USA. 1See details»
Leadership - AADI Bioscience
Neil Desai, PhD Founder, CEO and President Dr. Desai is the founder of Aadi and has served as Aadi’s President, Chief Executive Officer, and Chairman of Aadi’s board of directors since Aadi’s founding in October 2011. He is an …See details»
Aadi Bioscience, Inc Management Team | Org Chart
Aadibio.com; View Similar People. Related Companies Wellth. 129 $11.5m AQUAhydrate, Inc. 18 $12.7m Stability Healthcare. 317 $19.4m Ovation Fertility. 143 $19m Brentwood Associates. …See details»
Aadi Bioscience, Inc | LinkedIn
Aadi Bioscience, Inc Biotechnology Research Los Angeles, California 4,095 followers Aadi is a commercial-stage biopharmaceutical company focused on precision therapies for genetically-defined cancers.See details»
Aadi Bioscience - Crunchbase Company Profile
Aadi Bioscience, Inc. is a biopharmaceutical company developing precision therapies for genetically-defined cancers. Aadi’s primary goal is to bring transformational therapies to cancer patients with mTOR pathway driver …See details»
Aadi Bioscience - businessabc.net
Mar 2, 2025 Founded in 2019, Aadi Bioscience Inc., (ABI) is a clinical stage biotechnology company located in the San Francisco Bay Area, focusing on the development of novel …See details»
Aadi Bioscience, Inc. (AADI) Company Profile & Facts - Yahoo …
See the company profile for Aadi Bioscience, Inc. (AADI) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
Company - AADI Bioscience
Aadi Bioscience, Inc. is a commercial-stage biopharmaceutical company developing precision therapies for genetically-defined cancers. Aadi’s primary goal is to bring transformational …See details»
Org Chart Aadi Bioscience - The Official Board
Www.aadibio.com. has 17 executives +1 310 309 9036; Add an executive. Aadi Bioscience (AADI) News . Anything missing? We search for you. Print or download . CEO & President. Dave Lennon. Move. Chairman of the Board. …See details»
Aadi Bioscience 2025 Company Profile: Stock …
Aadi Bioscience General Information Description. Whitehawk Therapeutics Inc is a preclinical stage oncology therapeutics. The company is engaged in applying technologies to established tumor biology to efficiently deliver improved …See details»
Aadi Bioscience - Overview, News & Similar companies - ZoomInfo
Mar 6, 2024 Aadi Bioscience contact info: Phone number: (424) 744-8055 Website: www.aadibio.com What does Aadi Bioscience do? Aadi is a clinical-stage biopharmaceutical …See details»
Aadi Bioscience Transforms with In-Licensing of Novel ADC
Dec 20, 2024 Aadi is a precision oncology company with a vision to make bold choices in applying technology to efficiently deliver improved precision oncology therapies for people …See details»
Board of Directors - AADI Bioscience
Neil Desai, PhDFounder, CEO and President Dr. Desai is the founder of Aadi and has served as Aadi’s President, Chief Executive Officer and Chairman of Aadi’s board of directors since …See details»
Aadi buys preclinical ADCs, sells Fyarro to reboot business
Dec 20, 2024 The deal has secured Aadi rights to preclinical ADCs against PTK7, MUC16 and SEZ6. Aadi sees PTK7 as a target that can unlock indications including non-small cell lung …See details»
Aadi Bioscience Announces Closing of Merger with Aerpio …
LOS ANGELES, Aug. 26, 2021 (GLOBE NEWSWIRE) -- Aadi Bioscience, Inc. (“Aadi”) (Nasdaq: AADI), a clinical-stage biopharmaceutical company focusing on precision therapies for …See details»
Aadi Bioscience to Report Fourth Quarter and Full-Year 2024
Mar 14, 2025 --Aadi Bioscience, Inc. today announced that it will host a webcast to discuss fourth quarter and full-year 2024 financial results and provide recent corporate updates on …See details»
Careers - AADI Bioscience
Aadi Bioscience is proud to be an Equal Employment Opportunity employer committed to a diverse and dynamic workplace. We do not discriminate based upon race, religion, color, …See details»
Aadi Bioscience : Enters Agreement to Sell FYARRO® and …
Dec 20, 2024 Aadi is a precision oncology company with a vision to make bold choices in applying technology to efficiently deliver improved precision oncology therapies for people …See details»
Aadi Bioscience Transforms with In-Licensing of Novel ADC …
Dec 20, 2024 Participants may access a live webcast of the call and the associated slide presentation on these data through the “Investors & News” page of the Aadi Bioscience …See details»
Aadi Bioscience Announces Closing of Merger with Aerpio …
Aug 26, 2021 Management and Organization . Neil Desai, Ph.D., President and Chief Executive Officer and Director of Aadi will continue to lead the combined company along with the Aadi …See details»